vs

Side-by-side financial comparison of Bloom Energy Corp (BE) and Healthpeak Properties (DOC). Click either name above to swap in a different company.

Bloom Energy Corp is the larger business by last-quarter revenue ($751.1M vs $719.4M, roughly 1.0× Healthpeak Properties). Healthpeak Properties runs the higher net margin — 73.2% vs 9.4%, a 63.8% gap on every dollar of revenue. On growth, Healthpeak Properties posted the faster year-over-year revenue change (3.1% vs -3.4%). Over the past eight quarters, Bloom Energy Corp's revenue compounded faster (51.7% CAGR vs 8.9%).

KR Sridhar is an Indian American engineer, inventor, professor, and entrepreneur. He is the founder, chairman, and chief executive officer (CEO) of Bloom Energy. Prior, Sridhar was a professor of Aerospace and Mechanical Engineering and the Director of the Space Technologies Laboratory (STL) at the University of Arizona. He worked with and advised NASA, and is a member of the National Academy of Engineering.

Healthpeak Properties, Inc. is an American real estate investment trust that invests in real estate related to the healthcare industry including senior housing, life science, and medical offices. It was organized in 2007 in Maryland and headquartered in Denver, Colorado with offices in Irvine, Nashville and San Francisco. As of December 31, 2019, the company owned interests in 617 properties.

BE vs DOC — Head-to-Head

Bigger by revenue
BE
BE
1.0× larger
BE
$751.1M
$719.4M
DOC
Growing faster (revenue YoY)
DOC
DOC
+6.5% gap
DOC
3.1%
-3.4%
BE
Higher net margin
DOC
DOC
63.8% more per $
DOC
73.2%
9.4%
BE
Faster 2-yr revenue CAGR
BE
BE
Annualised
BE
51.7%
8.9%
DOC

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BE
BE
DOC
DOC
Revenue
$751.1M
$719.4M
Net Profit
$70.7M
$114.0M
Gross Margin
30.0%
Operating Margin
17.3%
17.4%
Net Margin
9.4%
73.2%
Revenue YoY
-3.4%
3.1%
Net Profit YoY
396.7%
2406.4%
EPS (diluted)
$0.44
$0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BE
BE
DOC
DOC
Q1 26
$751.1M
Q4 25
$772.8M
$719.4M
Q3 25
$513.3M
$705.9M
Q2 25
$396.3M
$694.3M
Q1 25
$319.3M
$702.9M
Q4 24
$567.0M
$698.0M
Q3 24
$321.8M
$700.4M
Q2 24
$326.5M
$695.5M
Net Profit
BE
BE
DOC
DOC
Q1 26
$70.7M
Q4 25
$1.4M
$114.0M
Q3 25
$-23.0M
$-117.1M
Q2 25
$-42.2M
$31.7M
Q1 25
$-23.4M
$42.8M
Q4 24
$105.2M
$4.5M
Q3 24
$-14.6M
$85.9M
Q2 24
$-61.2M
$146.0M
Gross Margin
BE
BE
DOC
DOC
Q1 26
30.0%
Q4 25
31.0%
Q3 25
29.5%
58.6%
Q2 25
27.0%
60.2%
Q1 25
27.8%
61.1%
Q4 24
38.7%
60.3%
Q3 24
24.5%
60.0%
Q2 24
21.0%
60.6%
Operating Margin
BE
BE
DOC
DOC
Q1 26
17.3%
Q4 25
11.3%
17.4%
Q3 25
1.5%
9.2%
Q2 25
-0.9%
5.7%
Q1 25
-6.0%
7.7%
Q4 24
18.5%
-2.2%
Q3 24
-3.0%
14.1%
Q2 24
-7.1%
22.3%
Net Margin
BE
BE
DOC
DOC
Q1 26
9.4%
Q4 25
0.2%
73.2%
Q3 25
-4.5%
-16.6%
Q2 25
-10.6%
4.6%
Q1 25
-7.3%
6.1%
Q4 24
18.5%
0.7%
Q3 24
-4.5%
12.3%
Q2 24
-18.7%
21.0%
EPS (diluted)
BE
BE
DOC
DOC
Q1 26
$0.44
Q4 25
$99.91
$0.16
Q3 25
$-100.00
$-0.17
Q2 25
$-0.18
$0.05
Q1 25
$-0.10
$0.06
Q4 24
$0.45
$0.02
Q3 24
$-0.06
$0.12
Q2 24
$-0.27
$0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BE
BE
DOC
DOC
Cash + ST InvestmentsLiquidity on hand
$467.5M
Total DebtLower is stronger
$9.8B
Stockholders' EquityBook value
$948.0K
$7.5B
Total Assets
$4.7B
$20.3B
Debt / EquityLower = less leverage
1.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BE
BE
DOC
DOC
Q1 26
Q4 25
$2.5B
$467.5M
Q3 25
$595.1M
$91.0M
Q2 25
$574.8M
$89.4M
Q1 25
$794.8M
$70.6M
Q4 24
$802.9M
$119.8M
Q3 24
$495.7M
$180.4M
Q2 24
$581.7M
$106.9M
Total Debt
BE
BE
DOC
DOC
Q1 26
Q4 25
$2.6B
$9.8B
Q3 25
$1.1B
$9.1B
Q2 25
$1.1B
$9.0B
Q1 25
$1.1B
$8.9B
Q4 24
$1.1B
$8.7B
Q3 24
$1.1B
$8.6B
Q2 24
$1.1B
$8.6B
Stockholders' Equity
BE
BE
DOC
DOC
Q1 26
$948.0K
Q4 25
$768.6M
$7.5B
Q3 25
$653.1M
$7.6B
Q2 25
$594.6M
$7.9B
Q1 25
$578.3M
$8.2B
Q4 24
$562.5M
$8.4B
Q3 24
$430.9M
$8.6B
Q2 24
$423.3M
$8.8B
Total Assets
BE
BE
DOC
DOC
Q1 26
$4.7B
Q4 25
$4.4B
$20.3B
Q3 25
$2.6B
$19.6B
Q2 25
$2.5B
$19.8B
Q1 25
$2.6B
$19.8B
Q4 24
$2.7B
$19.9B
Q3 24
$2.6B
$20.0B
Q2 24
$2.5B
$20.2B
Debt / Equity
BE
BE
DOC
DOC
Q1 26
Q4 25
3.41×
1.31×
Q3 25
1.73×
1.20×
Q2 25
1.91×
1.14×
Q1 25
1.96×
1.08×
Q4 24
2.01×
1.04×
Q3 24
2.62×
1.00×
Q2 24
2.66×
0.98×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BE
BE
DOC
DOC
Operating Cash FlowLast quarter
$1.3B
Free Cash FlowOCF − Capex
$357.0M
FCF MarginFCF / Revenue
49.6%
Capex IntensityCapex / Revenue
124.4%
Cash ConversionOCF / Net Profit
10.99×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BE
BE
DOC
DOC
Q1 26
Q4 25
$418.1M
$1.3B
Q3 25
$19.7M
$315.0M
Q2 25
$-213.1M
$363.5M
Q1 25
$-110.7M
$279.4M
Q4 24
$484.2M
$1.1B
Q3 24
$-69.5M
$318.2M
Q2 24
$-175.5M
$316.2M
Free Cash Flow
BE
BE
DOC
DOC
Q1 26
Q4 25
$395.1M
$357.0M
Q3 25
$7.4M
Q2 25
$-220.4M
Q1 25
$-124.9M
Q4 24
$473.1M
$333.7M
Q3 24
$-83.8M
Q2 24
$-187.5M
FCF Margin
BE
BE
DOC
DOC
Q1 26
Q4 25
51.1%
49.6%
Q3 25
1.4%
Q2 25
-55.6%
Q1 25
-39.1%
Q4 24
83.4%
47.8%
Q3 24
-26.0%
Q2 24
-57.4%
Capex Intensity
BE
BE
DOC
DOC
Q1 26
Q4 25
3.0%
124.4%
Q3 25
2.4%
Q2 25
1.8%
Q1 25
4.5%
Q4 24
2.0%
105.6%
Q3 24
4.4%
Q2 24
3.7%
Cash Conversion
BE
BE
DOC
DOC
Q1 26
Q4 25
293.18×
10.99×
Q3 25
Q2 25
11.48×
Q1 25
6.52×
Q4 24
4.60×
235.43×
Q3 24
3.71×
Q2 24
2.17×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BE
BE

Product$653.3M87%
Service$61.9M8%
Installation$25.9M3%
Electricity$9.9M1%

DOC
DOC

Segment breakdown not available.

Related Comparisons